Skip to main content
Clinical Trials/ACTRN12610000199011
ACTRN12610000199011
Not yet recruiting
Phase 4

In glaucoma or ocular hypertension, have the two presentations of bimatoprost 0.03% availabe in Brazil similar safety and efficacy profile?

Ophthalmology Department of the State University of Campinas0 sites54 target enrollmentMarch 9, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
glacoma
Sponsor
Ophthalmology Department of the State University of Campinas
Enrollment
54
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 9, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ophthalmology Department of the State University of Campinas

Eligibility Criteria

Inclusion Criteria

  • Ocular Hypertension:
  • \- intraocular pressure higher than 21mmHg with no medication
  • \-normal visual field test
  • \-normal optic nerve appearance
  • \-intraocular pressure higher than 21mmHg with no medication
  • \-glaucomatous visual filed test
  • \-glacuomatous optic nerve appearance

Exclusion Criteria

  • \- visual acuity worse than 20/40 (Snellen scale)
  • \- intraocular pressure higher than 36mmHg with medication
  • \- diabetes
  • \-intraocular laser or surgery on the last 6 months
  • \-ocular trauma on the last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials